Abstract
We present an unusual case of empyema of the gallbladder associated with a pyogenic liver abscess in a patient with Crohn’s disease on Infiiximab. It manifested by weakness, weight loss, and vague abdominal pain, which eventually localized to the right upper quadrant 4 days prior to admission. Diagnostic evaluation, which included ultrasonography and computed tomography, revealed cholelithiasis, gallbladder wall thickening, and a low-attenuation, complex mass in the left hepatic lobe. Cholecystectomy and open drainage of the liver abscess were successfully performed. There are few reports of intrahepatic abscess associated with Crohn’s disease. The relationship between acute cholecystitis and Crohn’s disease has also been documented. However, this report documents the unusual complication of pyogenic liver abscess secondary to acute cholecystitis in the unique population of Crohn’s disease patients on Infiiximab.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991;20:1–19.
Lorusso D, Silvana L, Mossa A, et al. Cholelithiasis in infiammatory bowel disease. Dis Colon Rect 1990;33:791–794.
Attili AF, DeSantis A, Capri R, et al. The natural history of gallstones: The GREPCO experience. Hepatology 1995;21:656–660.
Teague M, Baddour LM, Wruble LD. Liver abscess: A harbinger of Crohn’s disease. Am J Gastroenterol 1998; 83:1412–1414.
Mir-Madjlessi SH, McHenry MC, Farmer RG. Liver abscess in Crohn’s disease: Report of four cases and review of the literature. Gastroenterology 1986;91:987–993.
Allan RN. Extra-intestinal manifestations of infiammatory bowel disease. Clin Gastroenterol 1983;12:617–632.
Christophi C, Hughes ER. Hepatobiliary disorders in infissammatory bowel disease. Surg Gynecol Obstet 1985;160:189–193.
Vakil N, Hayne G, Sharma A, Hardy DJ, Slutsky A. Liver abscess in Crohn’s disease. Am J Gastroenterol 1994;89:1090–1095.
Brooke BN, Slaney G. Portal bacteremia in ulcerative colitis. Lancet 1958;1:1206–1207.
Lerman B, Garlock JH, Janowitz HD. Suppurative pylephlebitis with multiple liver abscesses complicating regional ileitis. Review of literature 1940–1960. Ann Surg 1962;155:441–448.
Taylor FW. Regional enteritis complicated by pylephlebitis and multiple liver abscesses. Am J Med 1949;7:838–840.
Kirsner JB, Shorter RG. Recent developments in non-specific infiammatory bowel disease (second of two parts). N Engl J Med 1982;306:837–848.
Baker AL, Kaplan MM, Norton RA, et al. Gallstones in infiammatory bowel disease. Dig Dis 1974;19:109–112.
Anderson H, Bosaeus I, Fasth S, et al. Cholelithiasis and urolithiasis in Crohn’s disease. Scand J Gastroenterol 1987;22:253–256.
Hutchinson R, Tyrrell PNM, Kumar D, et al. Pathogenesis of gallstones in Crohn’s disease. An alternative explanation. Gut 1994;35:94–97.
Lapidus A, Bangstad M, Astrom M, et al. The prevalence of gallstone disease in a defined cohort of patients with Crohn’s disease. Am J Gastroenterol 1999;94:1261–1266.
Heaton KW, Read AE. Gallstones in patients with disorders of the terminal ileum and disturbed bile salt metabolism. Br Med J 1969;3:494–496.
Brink MA, Slors JFM, Keulemans YCA, et al. Enterohepatic cycling of bilirubin: A putative mechanism for pigment gallstone formation in ileal Crohn’s disease. Gastroenterology 1999;116:1420–1427.
Lapidus A, Einarsson C. Bile composition in patients with ileal resection due to Crohn’s disease. Infiamm Bowel Dis 1998;4:89–94.
Dawes L, Stryker S, Rege R, et al. Gallbladder bile composition in Crohn’s disease. Surg Forum 1991;42:188–189.
Klatchko BA, Schwartz SI. Diagnostic and therapeutic approaches to pyogenic abscess of the liver. Surg Gynecol Obstet 1989;168:332–334.
Miedema BW, Dineen P. The diagnosis and treatment of pyogenic liver abscess. Ann Surg 1984;200:328–335.
Bertel CK, van Heerden JA, Sheedy PF. Treatment of pyogenic hepatic abscesses: Surgical vs. percutaneous drainage. Arch Surg 1986;121:554.
Robert JH, Mirescu D, et al. Critical review of the treatment of pyogenic hepatic abscess. Surg Gynecol Obstet 1992; 174:97.
Bakalakos EA, Melvin WS, Kirkpatrick R. Liver abscess secondary to intrahepatic perforation of the gallbladder, presenting as a liver mass. Am J Gastroenterol 1996;91:1644–1646.
Hanauer SB. Review article: Safety of infiiximab in clinical trials. Aliment Pharmacol Ther 1999;13:16–22.
Bresnihan B, Cunnane G. Infection complications associated with the use of biologic agents. Rheum Dis Clin North Am 2003;29:185–202.
Reichardt P, et al. Possible activation of an intramyocardial infiammatory process (Staphylococcus aureus) after treatment with infiiximab in a boy with Crohn disease. Eur J Pediatr 2002;161:281–283.
D’Haens GR. Infiiximab (Remicade), a new biological treatment for Crohn’s disease. Dig Liver Dis 1999;31:519–520.
Garnett WR, Yunker N. Treatment of Crohn’s disease with infiiximab. Am J Health System Pharmacy 2001;58:307–316.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patel, T.R., Patel, K.N. & Boyarsky, A.H. Staphylococcal liver abscess and acute cholecystitis in a patient with Crohn’s disease receiving infiiximab. J Gastrointest Surg 10, 105–110 (2006). https://doi.org/10.1016/j.gassur.2005.04.006
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2005.04.006